沙特阿拉伯当前的通用药物利用和相关的储蓄:来自私人索赔数据库的见解
Shabab AlGhamdi1, Ibrahim Abdulrahman Aljuffali2, Ahmed Hamdan Aljedai3
1Secretary General, Council of Health Insurance, Riyadh, Kingdom of Saudi Arabia.
Value in health regional issues
|May 29, 2025
概括
沙特阿拉伯的健康保险委员会 (CHI) 政策将仿制药的使用率从70%提高到76%,节省了3.3亿沙特里亚尔. 当地仿制药引领了这一趋势,预计这一趋势将继续下去.
科学领域:
- 卫生经济学 卫生经济学
- 制药政策 制药政策
- 公共卫生 公共卫生
背景情况:
- 通用替代药物是改善医疗保健准入和降低成本的关键策略.
- 沙特阿拉伯的医疗保险委员会 (CHI) 实施了一项政策 (第289号通函),以促进仿制药的使用.
- 缺乏关于这一具体政策对药物使用和财务结果的影响的数据.
研究的目的:
- 分析CHI第289号公告对沙特阿拉伯药物使用和财务结果的影响.
- 评估通用药物使用率和相关成本节省的趋势.
- 评估本地与进口仿制品牌的使用情况以及整体药品使用模式.
主要方法:
- 进行了一项为期10个月的回顾性观察研究 (2022年9月至2023年6月).
- 分析了来自国家公共卫生信息交换系统的每月汇总数据.
- 计算了仿制药的使用率和支出率,成本节约以及当地仿制药的采用率,并与2019年的数据进行了比较.
主要成果:
- 通用药的使用率从70%上升到76%,支出从38%上升到44%.
- 当地仿制药占利用率的最大份额 (45%),超过进口仿制药 (30%) 和品牌 (25%).
- 在10个月内,大约3.3亿沙特里亚尔的储蓄实现了,潜在的储蓄为2.28亿沙特里亚尔.
结论:
- CHI的第289号公告有效地促进了仿制药的使用.
- 观察到的仿制药使用量的增加与国际趋势一致,预计将持续下去.
- 该政策已经显示出显著的财务效益和积极转向本地仿制品选择.
相关概念视频
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
235
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
235
01:26Pharmaceutical Equivalents
247
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
247
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
246
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
246
01:28Structure-Activity Relationships and Drug Design
1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
01:15Drug Dosage Regimen: Overview
4.6K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.6K
01:27Combined Effects of Drugs: Synergism
7.2K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.2K